Source: Ludwig Burger and Sachin Ravikumar, YAHOO NEWS, 10/5/21

AstraZeneca has requested emergency approval from U.S. regulators for its antibody cocktail, the first protective shot other than vaccines against COVID-19, another potential major step in the global fight to combat the virus. While vaccines rely on an intact immune system to develop targeted antibodies and infection-fighting cells, Astra's biotech compound known as AZD7442 contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

For more of this story, click here.